GTBPVSNOMA• 28 Days (Normalized)
GTBP vs NOMA (GT Biopharma Inc. vs NOMADAR Corp.)
Showing Closing Date Range from Sep 7 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $6.16
+3.01%
GT Biopharma Inc.
Normalized Baseline0.00%
NOMA Performance $1.79
-9.6%
NOMADAR Corp.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+12.61 pts
GTBP outperforming by 12.61 percentage points
GTBPNOMA
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP NOMA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(19 dates)
| Date | GTBP Price | GTBP Gain (%) | NOMA Price | NOMA Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 05, 2026 | $6.16 | +3.01% | $1.79 | -9.60% | +12.61% |
| Oct 02, 2026 | $6.10 | +2.01% | $1.95 | -1.77% | +3.78% |
| Sep 30, 2026 | $- | $1.71 | -13.64% | - | |
| Sep 29, 2026 | $6.88 | +14.97% | $- | - | |
| Sep 28, 2026 | $6.80 | +13.71% | $- | - | |
| Sep 25, 2026 | $6.89 | +15.22% | $1.54 | -22.22% | +37.44% |
| Sep 24, 2026 | $6.83 | +14.21% | $1.53 | -22.73% | +36.94% |
| Sep 23, 2026 | $7.10 | +18.73% | $1.56 | -21.21% | +39.94% |
| Sep 22, 2026 | $- | $1.55 | -21.72% | - | |
| Sep 21, 2026 | $7.18 | +20.07% | $1.55 | -21.72% | +41.79% |
| Sep 18, 2026 | $7.16 | +19.73% | $1.60 | -19.19% | +38.92% |
| Sep 17, 2026 | $7.49 | +25.25% | $1.55 | -21.97% | +47.22% |
| Sep 16, 2026 | $7.81 | +30.60% | $1.45 | -26.77% | +57.37% |
| Sep 15, 2026 | $9.00 | +50.50% | $1.36 | -31.31% | +81.81% |
| Sep 14, 2026 | $11.63 | +94.48% | $1.42 | -28.28% | +122.76% |
Page 1 of 2